Even after decades of research, there is no cure for the disease HIV causes, AIDS. But lenacapavir, born out of research on ...

"I’d love for him to go in and meet the children that have now been infected with HIV because he cut that money." ...

A common medication used to treat HIV and hepatitis B may offer unexpected protection against Alzheimer's disease.

Existing drugs taken by thousands of people for another health condition may protect against dementia, a study suggests. US ...

It’s estimated that over 10 million people around the world develop Alzheimer’s disease annually,” said UVA Health researcher Jayakrishna Ambati, MD. “Our results suggest that taking these drugs could ...

Communities in the Kenya’s and Uganda’s shores of Lake Victoria, Copperbelt Province in Zambia, Eastern Cape Province in ...

While the Kyrgyz government fully covers HIV treatment, there’s a real risk that essential social and prevention services — post-release support, reintegration, temporary housing, documentation help, ...

The South accounts for nearly half the nation's new HIV diagnoses. Prevention programs are trying to stem the tide, and in Dallas County, they're working — but now they're facing funding cuts.

OraSure has sites at 150 Webster Street in Bethlehem, where it houses its corporate offices and research and development; as well as a manufacturing facility at 220 E. First Street in Bethlehem; and ...

Connecticut must ensure life saving medications and health care remain accessible to those who need them most.

Federal funding for a program that used dating apps to connect people with free HIV home tests - identifying nearly 7,000 new ...

The FDA granted Priority Review to lenacapavir for the prevention of HIV as pre-exposure prophylaxis (PrEP). Lenacapavir is a long-acting HIV-1 capsid inhibitor administered as a twice-yearly ...